Money stock in Armenia grows 3.7% to over amd 1346.3 billion in December

YEREVAN, February 1. /ARKA/. Money stock in Armenia reached over AMD 1346.3 billion by late December after growing 3.7% since late November, the National Statistical Service of Armenia reports referring to the central bank’s figures.

Cash outside of the banking system amounted to about AMD 384.1 billion against more than AMD 360.7 billion in late November, demand deposits in drams totaled AMD 161.7 billion against AMD 164.4 billion and time deposits in drams over AMD 192.2 billion against AMD 187.0 billion.

Deposits in foreign currencies totaled about AMD 608.4 billion in December against more than AMD 588.3 billion a month before and made up 45.2% of the country’s money stock.

Monetary multiplier went 0.12 points down, compared with November, to 1.97 in late December. ($1 – AMD 406.64). -0—

spot_img

POPULAR

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img